• Leading French independent pharmaceutical company
• Second French pharmaceutical company worldwide
• SERVIER is established in 140 countries
• 86% of SERVIER's sales are achieved internationally
• Consolidated turnover for the 2009/2010 financial year: €3.6 billion
• More than 25% of SERVIER's turnover is invested in Research and Development
• Worldwide workforce of almost 20,000, including nearly 3,000 in Research and Development
• SERVIER contributes 29% of the trade surplus of France's pharmaceutical industry

Key Figures for Australia:

The Australian subsidiary had a turnover in 2009 of $107 million.

Servier has grown its headcount almost 20 fold in the last twenty years whereby the company now employs over 200 staff in the Australia in departments such as Sales, Marketing, Clinical Research and Administration. It is projected this growth will continue in the coming years as we launch new products into different therapeutic areas.